Showing results (131-140 of 808) with videos related to
Sort By:
Pageof 81
Health Care Management Science|November 27, 2009
Erlang loss models for the static deployment of ambulancesMateo Restrepo, Shane G Henderson, Huseyin TopalogluBritish Journal of Pharmacology|December 7, 2007
Agonist-selective mechanisms of GPCR desensitizationE Kelly, C P Bailey, G HendersonCanadian Journal of Physiology and Pharmacology|July 23, 1998
Antinociceptive and morphine modulatory actions of spinal orphanin FQK H Jhamandas, M Sutak, G HendersonBritish Journal of Pharmacology|December 1, 1972
A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferensG Henderson, J Hughes, H W KosterlitzJournal of the Neurological Sciences|June 1, 1975
Cell counts in the human cerebral cortex using a traditional and an automatic methodG Henderson, B E Tomlinson, D WeightmanThe British Journal of Venereal Diseases|February 1, 1977
Immunofluorescent staining of Treponema pallidum and Treponema pertenue in tissues fixed by formalin and embedded in paraffin waxH T Al-Samarrai, W G HendersonThe Cochrane Database of Systematic Reviews|October 19, 2007
Formula milk versus maternal breast milk for feeding preterm or low birth weight infantsG Henderson, M Y Anthony, W McGuireThe Journal of Physiology|November 1, 1990
Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-D-aspartate receptorG Henderson, J W Johnson, P AscherEuropean Journal of Pharmacology|June 8, 1990
The sigma [corrected] ligand rimcazole antagonises (+)SKF 10,047, but not (+)3-PPP, in the mouse isolated vas deferensC Kennedy, G E Jarvis, G HendersonAsia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|January 22, 2021
Outcomes of Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma Based on Patient Age in 964 Eyes of 554 PatientsZeynep Bas, Lauren A Dalvin, Sameeksha Tadepalli, et al.Pageof 81